Skip to main content
. 2006 Dec;3(12):50–59.

Table 4.

Distribution of alprazolam ODT doses at Baseline, Week 4, and Endpoint

Starting Dose ITT N=67 Week 4 Dose ITT N=67 Endpoint Dose ITT N=67 Endpoint Dose Completers N=55
Mean (mg/day)a 0.81 0.94 0.74 0.80
Median (mg/day)a 0.75 0.88 0.50 0.50
Range, n (%)

  • 0 mg/day

  • >0–0.25 mg/day

  • >0.25–0.50mg/day

  • >0.50–0.75mg/day

  • >0.75–1.00mg/day

  • >1.00–1.50mg/day

  • >1.50–2.00mg/day

  • >2.00–3.00mg/day

  • >3.00mg/day

  • Not Availableb

  • 0

  • 5 (7.5%)

  • 27 (40.3%)

  • 3 (4.5%)

  • 21 (31.3%)

  • 9 (13.4%)

  • 1 (1.5%)

  • 0

  • 0

  • 1 (1.5%)

  • 0

  • 2 (3.0%)

  • 27 (40.3%)

  • 2 (3.0%)

  • 16 (23.9%)

  • 10 (14.9%)

  • 3 (4.5%)

  • 2 (3.0%)

  • 0

  • 5 (7.5%)

  • 41 (61.2%)

  • 2 (3.0%)

  • 11 (16.4%)

  • 0

  • 6 (9.0%)

  • 1 (1.5%)

  • 1 (1.5%)

  • 0

  • 0

  • 5 (7.5%)

  • 37 (67.3%)

  • 1 (1.8%)

  • 8 (14.5%)

  • 0

  • 5 (9.1%)

  • 1 (1.8%)

  • 1 (1.8%)

  • 0

  • 0

  • 2 (3.6%)
a

Means and medians calculated for subjects receiving any dose >0

b

Subjects for whom a dose was not recorded